Global Biological API Drug Manufacturing Market Research Report 2020
Table of Contents1 Biological API Drug Manufacturing Market Overview
1.1 Product Overview and Scope of Biological API Drug Manufacturing
1.2 Biological API Drug Manufacturing Segment by Type
1.2.1 Global Biological API Drug Manufacturing Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 In-House manufacturing
1.2.3 Contract manufacturing
1.3 Biological API Drug Manufacturing Segment by Application
1.3.1 Biological API Drug Manufacturing Sales Comparison by Application: 2020 VS 2026
1.3.2 Monoclonal Antibody (mAb) Therapies
1.3.3 Vaccines
1.3.4 Insulin Therapies
1.3.5 Interferon Therapies
1.3.6 Other
1.4 Global Biological API Drug Manufacturing Market Size Estimates and Forecasts
1.4.1 Global Biological API Drug Manufacturing Revenue 2015-2026
1.4.2 Global Biological API Drug Manufacturing Sales 2015-2026
1.4.3 Biological API Drug Manufacturing Market Size by Region: 2020 Versus 2026
1.5 Biological API Drug Manufacturing Industry
1.6 Biological API Drug Manufacturing Market Trends
2 Global Biological API Drug Manufacturing Market Competition by Manufacturers
2.1 Global Biological API Drug Manufacturing Sales Market Share by Manufacturers (2015-2020)
2.2 Global Biological API Drug Manufacturing Revenue Share by Manufacturers (2015-2020)
2.3 Global Biological API Drug Manufacturing Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Biological API Drug Manufacturing Manufacturing Sites, Area Served, Product Type
2.5 Biological API Drug Manufacturing Market Competitive Situation and Trends
2.5.1 Biological API Drug Manufacturing Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Biological API Drug Manufacturing Players (Opinion Leaders)
3 Biological API Drug Manufacturing Retrospective Market Scenario by Region
3.1 Global Biological API Drug Manufacturing Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Biological API Drug Manufacturing Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Biological API Drug Manufacturing Market Facts & Figures by Country
3.3.1 North America Biological API Drug Manufacturing Sales by Country
3.3.2 North America Biological API Drug Manufacturing Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Biological API Drug Manufacturing Market Facts & Figures by Country
3.4.1 Europe Biological API Drug Manufacturing Sales by Country
3.4.2 Europe Biological API Drug Manufacturing Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Biological API Drug Manufacturing Market Facts & Figures by Region
3.5.1 Asia Pacific Biological API Drug Manufacturing Sales by Region
3.5.2 Asia Pacific Biological API Drug Manufacturing Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Biological API Drug Manufacturing Market Facts & Figures by Country
3.6.1 Latin America Biological API Drug Manufacturing Sales by Country
3.6.2 Latin America Biological API Drug Manufacturing Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Biological API Drug Manufacturing Market Facts & Figures by Country
3.7.1 Middle East and Africa Biological API Drug Manufacturing Sales by Country
3.7.2 Middle East and Africa Biological API Drug Manufacturing Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Biological API Drug Manufacturing Historic Market Analysis by Type
4.1 Global Biological API Drug Manufacturing Sales Market Share by Type (2015-2020)
4.2 Global Biological API Drug Manufacturing Revenue Market Share by Type (2015-2020)
4.3 Global Biological API Drug Manufacturing Price Market Share by Type (2015-2020)
4.4 Global Biological API Drug Manufacturing Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Biological API Drug Manufacturing Historic Market Analysis by Application
5.1 Global Biological API Drug Manufacturing Sales Market Share by Application (2015-2020)
5.2 Global Biological API Drug Manufacturing Revenue Market Share by Application (2015-2020)
5.3 Global Biological API Drug Manufacturing Price by Application (2015-2020)
6 Company Profiles and Key Figures in Biological API Drug Manufacturing Business
6.1 Lonza
6.1.1 Corporation Information
6.1.2 Lonza Description, Business Overview and Total Revenue
6.1.3 Lonza Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Lonza Products Offered
6.1.5 Lonza Recent Development
6.2 Boehringer Ingelheim BioXcellence
6.2.1 Boehringer Ingelheim BioXcellence Corporation Information
6.2.2 Boehringer Ingelheim BioXcellence Description, Business Overview and Total Revenue
6.2.3 Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Boehringer Ingelheim BioXcellence Products Offered
6.2.5 Boehringer Ingelheim BioXcellence Recent Development
6.3 Celltrion
6.3.1 Celltrion Corporation Information
6.3.2 Celltrion Description, Business Overview and Total Revenue
6.3.3 Celltrion Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Celltrion Products Offered
6.3.5 Celltrion Recent Development
6.4 DSM
6.4.1 DSM Corporation Information
6.4.2 DSM Description, Business Overview and Total Revenue
6.4.3 DSM Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2015-2020)
6.4.4 DSM Products Offered
6.4.5 DSM Recent Development
6.5 Samsung BioLogics
6.5.1 Samsung BioLogics Corporation Information
6.5.2 Samsung BioLogics Description, Business Overview and Total Revenue
6.5.3 Samsung BioLogics Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Samsung BioLogics Products Offered
6.5.5 Samsung BioLogics Recent Development
6.6 Fujifilm Diosynth Biotechnologies
6.6.1 Fujifilm Diosynth Biotechnologies Corporation Information
6.6.2 Fujifilm Diosynth Biotechnologies Description, Business Overview and Total Revenue
6.6.3 Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Fujifilm Diosynth Biotechnologies Products Offered
6.6.5 Fujifilm Diosynth Biotechnologies Recent Development
6.7 Cytovance Biologics
6.6.1 Cytovance Biologics Corporation Information
6.6.2 Cytovance Biologics Description, Business Overview and Total Revenue
6.6.3 Cytovance Biologics Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Cytovance Biologics Products Offered
6.7.5 Cytovance Biologics Recent Development
6.8 AbbVie
6.8.1 AbbVie Corporation Information
6.8.2 AbbVie Description, Business Overview and Total Revenue
6.8.3 AbbVie Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2015-2020)
6.8.4 AbbVie Products Offered
6.8.5 AbbVie Recent Development
6.9 Baxter
6.9.1 Baxter Corporation Information
6.9.2 Baxter Description, Business Overview and Total Revenue
6.9.3 Baxter Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Baxter Products Offered
6.9.5 Baxter Recent Development
6.10 CEPiA Sanofi
6.10.1 CEPiA Sanofi Corporation Information
6.10.2 CEPiA Sanofi Description, Business Overview and Total Revenue
6.10.3 CEPiA Sanofi Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2015-2020)
6.10.4 CEPiA Sanofi Products Offered
6.10.5 CEPiA Sanofi Recent Development
6.11 GSK
6.11.1 GSK Corporation Information
6.11.2 GSK Biological API Drug Manufacturing Description, Business Overview and Total Revenue
6.11.3 GSK Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2015-2020)
6.11.4 GSK Products Offered
6.11.5 GSK Recent Development
6.12 Pfizer CentreOne
6.12.1 Pfizer CentreOne Corporation Information
6.12.2 Pfizer CentreOne Biological API Drug Manufacturing Description, Business Overview and Total Revenue
6.12.3 Pfizer CentreOne Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Pfizer CentreOne Products Offered
6.12.5 Pfizer CentreOne Recent Development
6.13 Sandoz
6.13.1 Sandoz Corporation Information
6.13.2 Sandoz Biological API Drug Manufacturing Description, Business Overview and Total Revenue
6.13.3 Sandoz Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Sandoz Products Offered
6.13.5 Sandoz Recent Development
6.14 Vetter
6.14.1 Vetter Corporation Information
6.14.2 Vetter Biological API Drug Manufacturing Description, Business Overview and Total Revenue
6.14.3 Vetter Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Vetter Products Offered
6.14.5 Vetter Recent Development
6.15 Wuxi Biologics
6.15.1 Wuxi Biologics Corporation Information
6.15.2 Wuxi Biologics Biological API Drug Manufacturing Description, Business Overview and Total Revenue
6.15.3 Wuxi Biologics Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Wuxi Biologics Products Offered
6.15.5 Wuxi Biologics Recent Development
7 Biological API Drug Manufacturing Manufacturing Cost Analysis
7.1 Biological API Drug Manufacturing Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Biological API Drug Manufacturing
7.4 Biological API Drug Manufacturing Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Biological API Drug Manufacturing Distributors List
8.3 Biological API Drug Manufacturing Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Biological API Drug Manufacturing Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Biological API Drug Manufacturing by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Biological API Drug Manufacturing by Type (2021-2026)
10.2 Biological API Drug Manufacturing Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Biological API Drug Manufacturing by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Biological API Drug Manufacturing by Application (2021-2026)
10.3 Biological API Drug Manufacturing Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Biological API Drug Manufacturing by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Biological API Drug Manufacturing by Region (2021-2026)
10.4 North America Biological API Drug Manufacturing Estimates and Projections (2021-2026)
10.5 Europe Biological API Drug Manufacturing Estimates and Projections (2021-2026)
10.6 Asia Pacific Biological API Drug Manufacturing Estimates and Projections (2021-2026)
10.7 Latin America Biological API Drug Manufacturing Estimates and Projections (2021-2026)
10.8 Middle East and Africa Biological API Drug Manufacturing Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesTable 1. Global Biological API Drug Manufacturing Sales (K MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Biological API Drug Manufacturing Sales (K MT) Comparison by Application: 2020 VS 2026
Table 3. Global Biological API Drug Manufacturing Market Size by Type (K MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Biological API Drug Manufacturing Manufacturers Covered in This Study
Table 5. Global Biological API Drug Manufacturing Sales (K MT) by Manufacturers (2015-2020)
Table 6. Global Biological API Drug Manufacturing Sales Share by Manufacturers (2015-2020)
Table 7. Global Biological API Drug Manufacturing Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Biological API Drug Manufacturing Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Biological API Drug Manufacturing Average Price (USD/MT) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Biological API Drug Manufacturing Sales Sites and Area Served
Table 11. Manufacturers Biological API Drug Manufacturing Product Types
Table 12. Global Biological API Drug Manufacturing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Biological API Drug Manufacturing by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biological API Drug Manufacturing as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Biological API Drug Manufacturing Players
Table 16. Global Biological API Drug Manufacturing Sales (K MT) by Region (2015-2020)
Table 17. Global Biological API Drug Manufacturing Sales Market Share by Region (2015-2020)
Table 18. Global Biological API Drug Manufacturing Revenue (Million US$) by Region (2015-2020)
Table 19. Global Biological API Drug Manufacturing Revenue Market Share by Region (2015-2020)
Table 20. North America Biological API Drug Manufacturing Sales by Country (2015-2020) (K MT)
Table 21. North America Biological API Drug Manufacturing Sales Market Share by Country (2015-2020)
Table 22. North America Biological API Drug Manufacturing Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Biological API Drug Manufacturing Revenue Market Share by Country (2015-2020)
Table 24. Europe Biological API Drug Manufacturing Sales by Country (2015-2020) (K MT)
Table 25. Europe Biological API Drug Manufacturing Sales Market Share by Country (2015-2020)
Table 26. Europe Biological API Drug Manufacturing Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Biological API Drug Manufacturing Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Biological API Drug Manufacturing Sales by Region (2015-2020) (K MT)
Table 29. Asia Pacific Biological API Drug Manufacturing Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Biological API Drug Manufacturing Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Biological API Drug Manufacturing Revenue Market Share by Region (2015-2020)
Table 32. Latin America Biological API Drug Manufacturing Sales by Country (2015-2020) (K MT)
Table 33. Latin America Biological API Drug Manufacturing Sales Market Share by Country (2015-2020)
Table 34. Latin America Biological API Drug Manufacturing Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Biological API Drug Manufacturing Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Biological API Drug Manufacturing Sales by Country (2015-2020) (K MT)
Table 37. Middle East and Africa Biological API Drug Manufacturing Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Biological API Drug Manufacturing Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Biological API Drug Manufacturing Revenue Market Share by Country (2015-2020)
Table 40. Global Biological API Drug Manufacturing Sales (K MT) by Type (2015-2020)
Table 41. Global Biological API Drug Manufacturing Sales Share by Type (2015-2020)
Table 42. Global Biological API Drug Manufacturing Revenue (Million US$) by Type (2015-2020)
Table 43. Global Biological API Drug Manufacturing Revenue Share by Type (2015-2020)
Table 44. Global Biological API Drug Manufacturing Price (USD/MT) by Type (2015-2020)
Table 45. Global Biological API Drug Manufacturing Sales (K MT) by Application (2015-2020)
Table 46. Global Biological API Drug Manufacturing Sales Market Share by Application (2015-2020)
Table 47. Global Biological API Drug Manufacturing Sales Growth Rate by Application (2015-2020)
Table 48. Lonza Biological API Drug Manufacturing Corporation Information
Table 49. Lonza Description and Business Overview
Table 50. Lonza Biological API Drug Manufacturing Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 51. Lonza Main Product
Table 52. Lonza Recent Development
Table 53. Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Corporation Information
Table 54. Boehringer Ingelheim BioXcellence Corporation Information
Table 55. Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 56. Boehringer Ingelheim BioXcellence Main Product
Table 57. Boehringer Ingelheim BioXcellence Recent Development
Table 58. Celltrion Biological API Drug Manufacturing Corporation Information
Table 59. Celltrion Corporation Information
Table 60. Celltrion Biological API Drug Manufacturing Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 61. Celltrion Main Product
Table 62. Celltrion Recent Development
Table 63. DSM Biological API Drug Manufacturing Corporation Information
Table 64. DSM Corporation Information
Table 65. DSM Biological API Drug Manufacturing Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 66. DSM Main Product
Table 67. DSM Recent Development
Table 68. Samsung BioLogics Biological API Drug Manufacturing Corporation Information
Table 69. Samsung BioLogics Corporation Information
Table 70. Samsung BioLogics Biological API Drug Manufacturing Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 71. Samsung BioLogics Main Product
Table 72. Samsung BioLogics Recent Development
Table 73. Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Corporation Information
Table 74. Fujifilm Diosynth Biotechnologies Corporation Information
Table 75. Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 76. Fujifilm Diosynth Biotechnologies Main Product
Table 77. Fujifilm Diosynth Biotechnologies Recent Development
Table 78. Cytovance Biologics Biological API Drug Manufacturing Corporation Information
Table 79. Cytovance Biologics Corporation Information
Table 80. Cytovance Biologics Biological API Drug Manufacturing Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. Cytovance Biologics Main Product
Table 82. Cytovance Biologics Recent Development
Table 83. AbbVie Biological API Drug Manufacturing Corporation Information
Table 84. AbbVie Corporation Information
Table 85. AbbVie Biological API Drug Manufacturing Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 86. AbbVie Main Product
Table 87. AbbVie Recent Development
Table 88. Baxter Biological API Drug Manufacturing Corporation Information
Table 89. Baxter Corporation Information
Table 90. Baxter Biological API Drug Manufacturing Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 91. Baxter Main Product
Table 92. Baxter Recent Development
Table 93. CEPiA Sanofi Biological API Drug Manufacturing Corporation Information
Table 94. CEPiA Sanofi Corporation Information
Table 95. CEPiA Sanofi Biological API Drug Manufacturing Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 96. CEPiA Sanofi Main Product
Table 97. CEPiA Sanofi Recent Development
Table 98. GSK Biological API Drug Manufacturing Corporation Information
Table 99. GSK Corporation Information
Table 100. GSK Biological API Drug Manufacturing Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 101. GSK Main Product
Table 102. GSK Recent Development
Table 103. Pfizer CentreOne Biological API Drug Manufacturing Corporation Information
Table 104. Pfizer CentreOne Corporation Information
Table 105. Pfizer CentreOne Biological API Drug Manufacturing Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 106. Pfizer CentreOne Main Product
Table 107. Pfizer CentreOne Recent Development
Table 108. Sandoz Biological API Drug Manufacturing Corporation Information
Table 109. Sandoz Corporation Information
Table 110. Sandoz Biological API Drug Manufacturing Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 111. Sandoz Main Product
Table 112. Sandoz Recent Development
Table 113. Vetter Biological API Drug Manufacturing Corporation Information
Table 114. Vetter Corporation Information
Table 115. Vetter Biological API Drug Manufacturing Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 116. Vetter Main Product
Table 117. Vetter Recent Development
Table 118. Wuxi Biologics Biological API Drug Manufacturing Corporation Information
Table 119. Wuxi Biologics Corporation Information
Table 120. Wuxi Biologics Biological API Drug Manufacturing Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 121. Wuxi Biologics Main Product
Table 122. Wuxi Biologics Recent Development
Table 123. Sales Base and Market Concentration Rate of Raw Material
Table 124. Key Suppliers of Raw Materials
Table 125. Biological API Drug Manufacturing Distributors List
Table 126. Biological API Drug Manufacturing Customers List
Table 127. Market Key Trends
Table 128. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 129. Key Challenges
Table 130. Global Biological API Drug Manufacturing Sales (K MT) Forecast by Type (2021-2026)
Table 131. Global Biological API Drug Manufacturing Sales Market Share Forecast by Type (2021-2026)
Table 132. Global Biological API Drug Manufacturing Revenue (Million US$) Forecast by Type (2021-2026)
Table 133. Global Biological API Drug Manufacturing Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 134. Global Biological API Drug Manufacturing Sales (K MT) Forecast by Application (2021-2026)
Table 135. Global Biological API Drug Manufacturing Revenue (Million US$) Forecast by Application (2021-2026)
Table 136. Global Biological API Drug Manufacturing Sales (K MT) Forecast by Region (2021-2026)
Table 137. Global Biological API Drug Manufacturing Sales Market Share Forecast by Region (2021-2026)
Table 138. Global Biological API Drug Manufacturing Revenue Forecast by Region (2021-2026) (US$ Million)
Table 139. Global Biological API Drug Manufacturing Revenue Market Share Forecast by Region (2021-2026)
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of FiguresFigure 1. Picture of Biological API Drug Manufacturing
Figure 2. Global Biological API Drug Manufacturing Sales Market Share by Type: 2020 VS 2026
Figure 3. In-House manufacturing Product Picture
Figure 4. Contract manufacturing Product Picture
Figure 5. Global Biological API Drug Manufacturing Consumption Market Share by Application: 2020 VS 2026
Figure 6. Monoclonal Antibody (mAb) Therapies
Figure 7. Vaccines
Figure 8. Insulin Therapies
Figure 9. Interferon Therapies
Figure 10. Other
Figure 11. Global Biological API Drug Manufacturing Market Size 2015-2026 (US$ Million)
Figure 12. Global Biological API Drug Manufacturing Sales Capacity (K MT) (2015-2026)
Figure 13. Global Biological API Drug Manufacturing Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Biological API Drug Manufacturing Sales Share by Manufacturers in 2020
Figure 15. Global Biological API Drug Manufacturing Revenue Share by Manufacturers in 2019
Figure 16. The Global 5 and 10 Largest Players: Market Share by Biological API Drug Manufacturing Revenue in 2019
Figure 17. Biological API Drug Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Biological API Drug Manufacturing Sales Market Share by Region (2015-2020)
Figure 19. Global Biological API Drug Manufacturing Sales Market Share by Region in 2019
Figure 20. Global Biological API Drug Manufacturing Revenue Market Share by Region (2015-2020)
Figure 21. Global Biological API Drug Manufacturing Revenue Market Share by Region in 2019
Figure 22. North America Biological API Drug Manufacturing Sales Market Share by Country in 2019
Figure 23. North America Biological API Drug Manufacturing Revenue Market Share by Country in 2019
Figure 24. U.S. Biological API Drug Manufacturing Sales Growth Rate (2015-2020) (K MT)
Figure 25. U.S. Biological API Drug Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Canada Biological API Drug Manufacturing Sales Growth Rate (2015-2020) (K MT)
Figure 27. Canada Biological API Drug Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Europe Biological API Drug Manufacturing Sales Market Share by Country in 2019
Figure 29. Europe Biological API Drug Manufacturing Revenue Market Share by Country in 2019
Figure 30. Germany Biological API Drug Manufacturing Sales Growth Rate (2015-2020) (K MT)
Figure 31. Germany Biological API Drug Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. France Biological API Drug Manufacturing Sales Growth Rate (2015-2020) (K MT)
Figure 33. France Biological API Drug Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. U.K. Biological API Drug Manufacturing Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.K. Biological API Drug Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Italy Biological API Drug Manufacturing Sales Growth Rate (2015-2020) (K MT)
Figure 37. Italy Biological API Drug Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Russia Biological API Drug Manufacturing Sales Growth Rate (2015-2020) (K MT)
Figure 39. Russia Biological API Drug Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Asia Pacific Biological API Drug Manufacturing Sales Market Share by Region in 2019
Figure 41. Asia Pacific Biological API Drug Manufacturing Revenue Market Share by Region in 2019
Figure 42. China Biological API Drug Manufacturing Sales Growth Rate (2015-2020) (K MT)
Figure 43. China Biological API Drug Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Japan Biological API Drug Manufacturing Sales Growth Rate (2015-2020) (K MT)
Figure 45. Japan Biological API Drug Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. South Korea Biological API Drug Manufacturing Sales Growth Rate (2015-2020) (K MT)
Figure 47. South Korea Biological API Drug Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. India Biological API Drug Manufacturing Sales Growth Rate (2015-2020) (K MT)
Figure 49. India Biological API Drug Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Australia Biological API Drug Manufacturing Sales Growth Rate (2015-2020) (K MT)
Figure 51. Australia Biological API Drug Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Taiwan Biological API Drug Manufacturing Sales Growth Rate (2015-2020) (K MT)
Figure 53. Taiwan Biological API Drug Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Indonesia Biological API Drug Manufacturing Sales Growth Rate (2015-2020) (K MT)
Figure 55. Indonesia Biological API Drug Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Thailand Biological API Drug Manufacturing Sales Growth Rate (2015-2020) (K MT)
Figure 57. Thailand Biological API Drug Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Malaysia Biological API Drug Manufacturing Sales Growth Rate (2015-2020) (K MT)
Figure 59. Malaysia Biological API Drug Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Philippines Biological API Drug Manufacturing Sales Growth Rate (2015-2020) (K MT)
Figure 61. Philippines Biological API Drug Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Vietnam Biological API Drug Manufacturing Sales Growth Rate (2015-2020) (K MT)
Figure 63. Vietnam Biological API Drug Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Latin America Biological API Drug Manufacturing Sales Market Share by Country in 2019
Figure 65. Latin America Biological API Drug Manufacturing Revenue Market Share by Country in 2019
Figure 66. Mexico Biological API Drug Manufacturing Sales Growth Rate (2015-2020) (K MT)
Figure 67. Mexico Biological API Drug Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Brazil Biological API Drug Manufacturing Sales Growth Rate (2015-2020) (K MT)
Figure 69. Brazil Biological API Drug Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Argentina Biological API Drug Manufacturing Sales Growth Rate (2015-2020) (K MT)
Figure 71. Argentina Biological API Drug Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Middle East and Africa Biological API Drug Manufacturing Sales Market Share by Country in 2019
Figure 73. Middle East and Africa Biological API Drug Manufacturing Revenue Market Share by Country in 2019
Figure 74. Turkey Biological API Drug Manufacturing Sales Growth Rate (2015-2020) (K MT)
Figure 75. Turkey Biological API Drug Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Saudi Arabia Biological API Drug Manufacturing Sales Growth Rate (2015-2020) (K MT)
Figure 77. Saudi Arabia Biological API Drug Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. U.A.E Biological API Drug Manufacturing Sales Growth Rate (2015-2020) (K MT)
Figure 79. U.A.E Biological API Drug Manufacturing Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Sales Market Share of Biological API Drug Manufacturing by Type (2015-2020)
Figure 81. Sales Market Share of Biological API Drug Manufacturing by Type in 2019
Figure 82. Revenue Share of Biological API Drug Manufacturing by Type (2015-2020)
Figure 83. Revenue Market Share of Biological API Drug Manufacturing by Type in 2019
Figure 84. Global Biological API Drug Manufacturing Sales Growth by Type (2015-2020) (K MT)
Figure 85. Global Biological API Drug Manufacturing Sales Market Share by Application (2015-2020)
Figure 86. Global Biological API Drug Manufacturing Sales Market Share by Application in 2019
Figure 87. Global Revenue Share of Biological API Drug Manufacturing by Application (2015-2020)
Figure 88. Global Revenue Share of Biological API Drug Manufacturing by Application in 2020
Figure 89. Lonza Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Boehringer Ingelheim BioXcellence Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Celltrion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. DSM Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Samsung BioLogics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Fujifilm Diosynth Biotechnologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Cytovance Biologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 9